GSK
GSK’s Tyverb fails late-stage trial in breast cancer
December 12, 2011Research and Development, Sales and Marketing GSK, Tyverb, breast cancer
GlaxoSmithKline’s Tyverb has failed to help women with HER2 positive breast cancer increase their survival. The TEACH study’s primary objective …
GlaxoSmithKline moves closer to green power goals
December 6, 2011Manufacturing and Production GSK, manufacturing
GlaxoSmithKline took a step closer to becoming a generator of electricity in a bid to offset the high energy demands …
Pharma manufacturing news in brief
December 6, 2011Manufacturing and Production GSK, Hospira, PharmaS, UPS, Uquifa, Vivimed
India’s Vivimed buys Spanish API maker, Hospira tries to spend its way out of manufacturing woes, plus updates from PharmaS, …
Abbott expands diagnostic pact with GlaxoSmithKline
November 29, 2011Research and Development, Sales and Marketing Abbott, Cancer, GSK, non-small cell lung cancer
Abbott will develop a diagnostic kit for GlaxoSmithKline’s new lung cancer drug candidate. This is an expansion of a …
UK government drops Cervarix for Gardasil
November 28, 2011Sales and Marketing Cervarix, GSK, Gardasil, MSD, Sanofi
The UK government has performed a U-turn on its HPV vaccine programme by favouring Sanofi and MSD’s Gardasil over GlaxoSmithKline’s …
Big pharma counts cost of R&D decline
November 23, 2011Research and Development Deloitte, GSK, IIR, R&D productivity
Leading pharma firms are getting around 30% less on their investments in research and development compared to last year, according …
GSK taps Alnylam tech for vaccine production
November 7, 2011Manufacturing and Production, Sales and Marketing Alnylam, GSK, vaccines
GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …
GSK, Pfizer joint venture to start manufacturing ops in Russia
November 4, 2011Manufacturing and Production GSK, Pfizer, manufacturing
A joint venture set up by GlaxoSmithKline and Pfizer is planning to start manufacturing in Russia thanks to a partnership …
GSK pays $3 billion to settle US marketing probe
November 3, 2011Sales and Marketing GSK, compliance, federal investigation
GlaxoSmithKline has agreed to pay $3 billion to settle US government investigations into the sales and marketing of diabetes drug …
GSK sees strong Q3 after battling headwinds
October 27, 2011Business Services, Sales and Marketing GSK, GSK. Q3, Q3
GlaxoSmithKline has posted a set of healthy figures for the third quarter, underlying its return to growth after a tough …
Flamel secures production contract for GSK heart failure drug
October 25, 2011Manufacturing and Production Coreg CR, Flamel, GSK, manufacturing
France’s Flamel Technologies has won a long-term contract from GlaxoSmithKline focusing on the production of the drugmaker’s Coreg CR heart …
Rumours abound on GSK-HGS takeover bid
October 20, 2011Research and Development, Sales and Marketing Benlysta, GSK, HGS
Rumours are gathering pace that GlaxoSmithKline may launch a takeover bid for struggling US firm Human Genome Sciences. British tabloid …
GSK planning job cuts at Quebec vaccines plant
October 18, 2011Manufacturing and Production Canada, GSK, Quebec, vaccines
GlaxoSmithKline has decided to cut around 9% of its workforce in Quebec City, Canada, with a vaccines manufacturing plant bearing …
NICE says no to lupus treatment
September 30, 2011Sales and Marketing Benylsta, GSK, Lupus, NICE
NICE has rejected GSK’s new lupus treatment Benlysta in draft guidance.Co-developed with biotech company HGS, the drug has been hailed …
McLaren alliance to turbocharge GSK research
September 16, 2011Manufacturing and Production, Research and Development GSK, manufacturing and production news, pharma manufacturing news, research and development news
GlaxoSmithKline has turned to the engineering expertise of Formula 1 racing team McLaren in an innovative alliance designed to transform …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
